Sign in

CIK 0001401667 · Accelerated filer<br>Smaller reporting company

PUMA BIOTECHNOLOGY, INC.

Sign in to watch
Ticker
PBYI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770683487
Phone
(424) 248-6500
Business address
10880 WILSHIRE BLVD., SUITE 1700, LOS ANGELES, CA
Former names
INNOVATIVE ACQUISITIONS CORP
  1. 4 Planned sale Chief Financial Officer sold 9,522 shares at an average $3.53 ($33,649)
  2. 4 Planned sale See Remarks sold 7,817 shares at an average $3.53 ($27,624)
  3. 4 Planned sale President and CEO sold 47,172 shares at an average $3.53 ($166,702)
  4. 4 Planned sale Director sold 10,800 shares at $3.40 ($36,720)
  5. 4 Planned sale Director sold 8,100 shares at $3.39 ($27,459)
  6. 4 Planned sale Director sold 27,000 shares at $3.40 ($91,800)
  7. 4 Planned sale Director sold 22,000 shares at $3.40 ($74,800)
  8. 4 Planned sale Director sold 11,610 shares at $3.40 ($39,474)
  9. 4 Planned sale Director sold 12,150 shares at $3.40 ($41,310)
  10. 4 Grant or award Director acquired 27,000 shares (grant or award)
  11. 4 Grant or award Director acquired 27,000 shares (grant or award)
  12. 4 Grant or award Director acquired 27,000 shares (grant or award)
  13. 4 Grant or award Director acquired 27,000 shares (grant or award)
  14. 4 Grant or award Director acquired 27,000 shares (grant or award)
  15. 4 Grant or award Director acquired 27,000 shares (grant or award)
  16. 4 Grant or award Director acquired 27,000 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 61,456 shares (grant or award)
  18. 4 Grant or award Chief Commercial Officer acquired 47,841 shares (grant or award)
  19. 4 Grant or award See Remarks acquired 48,117 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 198,399 shares (grant or award)

Page 2 of 24 · 471 filings